enkephalin, ser(2), leu(5), thr(6)- has been researched along with cyproheptadine in 2 studies
Studies (enkephalin, ser(2), leu(5), thr(6)-) | Trials (enkephalin, ser(2), leu(5), thr(6)-) | Recent Studies (post-2010) (enkephalin, ser(2), leu(5), thr(6)-) | Studies (cyproheptadine) | Trials (cyproheptadine) | Recent Studies (post-2010) (cyproheptadine) |
---|---|---|---|---|---|
224 | 0 | 5 | 2,297 | 262 | 201 |
Protein | Taxonomy | enkephalin, ser(2), leu(5), thr(6)- (IC50) | cyproheptadine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.0024 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.564 | |
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.035 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.016 | |
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0031 | |
Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.0038 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.283 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.016 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.164 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0031 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.038 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.275 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.122 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.046 | |
D(1A) dopamine receptor | Homo sapiens (human) | 0.158 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.564 | |
Histamine H2 receptor | Homo sapiens (human) | 0.198 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.107 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.001 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0024 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.122 | |
5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0031 | |
Histamine H1 receptor | Homo sapiens (human) | 0.0037 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.048 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0094 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.281 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.14 | |
Histone-lysine N-methyltransferase SETD7 | Homo sapiens (human) | 2.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheĭdo, MA; Idova, GV | 2 |
2 other study(ies) available for enkephalin, ser(2), leu(5), thr(6)- and cyproheptadine
Article | Year |
---|---|
[The participation of the delta opioid receptors in immunomodulation].
Topics: Animals; Cyproheptadine; Enkephalin, Leucine; Haloperidol; Immunization; Male; Mice; Mice, Inbred CBA; Narcotic Antagonists; Neuroimmunomodulation; Pituitary Gland; Receptors, Opioid, delta; Thymus Gland | 1993 |
[Effect of opioid peptides on immunomodulation].
Topics: Animals; Cyproheptadine; Dopamine D2 Receptor Antagonists; Dynorphins; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalins; Haloperidol; Male; Mice; Mice, Inbred CBA; Neuroimmunomodulation; Pituitary Gland; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Receptors, Serotonin; Spleen | 1998 |